Dr. Heestand is a board-certified medical oncologist with a focus on gastrointestinal cancers, primarily hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer. He currently serves as the medical oncology champion of the Stanford Hepatobiliary Tumor Board, as well as the principal investigator of multiple clinical trials. He also collaborates with campus laboratories to help develop new biomarker and treatment technologies. Dr. Heestand is a member of the ECOG-ACRIN gastrointestinal committee and serves as a representative to the NCI Hepatobiliary Task Force. He is also the director of the Stanford Medical Oncology Fellowship Program.
Dr. Heestand and his team take great pride in helping patients and their families face gastrointestinal cancer.
Outside of the clinic, Dr. Heestand enjoys playing the piano, teaching his kids about music, cooking for friends and family, and surfing the internet for interesting things to read.
- Hepatocellular Carcinoma
- Gallbladder Cancer
- Gastrointestinal Cancers
- Medical Oncology
Clinical Associate Professor, Medicine - Oncology
Oncology Fellowship Director, Stanford University (2017 - Present)
Medical Education: University of Southern California Keck School of Medicine Registrar (2004) CA
Board Certification: American Board of Internal Medicine, Medical Oncology (2010)
Board Certification: American Board of Internal Medicine, Hematology (2010)
Fellowship: Stanford University Hematology and Oncology Fellowship (2010) CA
Residency: University of California Davis (2007) CA
Undergraduate, Harvard College (1998)